Press Releases

Ra Medical Systems to Report 2021 Fourth Quarter and Full Year Financial Results on March 23, 2022

CARLSBAD, Calif.--(BUSINESS WIRE)-- Ra Medical Systems, Inc. (NYSE American: RMED) announces that it will report 2021 fourth quarter and full year financial results after market close on Wednesday, March 23. Ra Medical management will hold an investment community conference call that day at 1:30 p.m. Pacific time (4:30 p.m. Eastern time) to discuss financial results and provide a company update.

Pre-Registration

 

Participants can pre-register for the conference call here

 

 

 

 

 

Callers who pre-register will be given a conference passcode and unique PIN to gain immediate access to the call and bypass the live operator. Participants may pre-register at any time, including up to and after the call start time.

 

 

 

 

Live Call:

 

Those who choose not to pre-register can access the live conference by dialing:

 

 

U.S.

866-777-2509

 

 

International

412-317-5413

   

 

 

Request to join the Ra Medical Systems conference call

 

 

 

 

Live Webcast:

 

Ra Medical Systems Website

   

 

 

The webcast will be archived for 30 days.

 

 

 

 

Replay:

 

U.S.

877-344-7529

 

 

Canada

855-669-9658

 

 

International

412-317-0088

 

 

Passcode

9255498

 

 

 

 

 

 

The replay will be available for 48 hours

About Ra Medical Systems

Ra Medical Systems manufactures the DABRA excimer laser and catheters for the treatment of certain vascular diseases. DABRA has been cleared by the FDA for crossing chronic total occlusions in patients with symptomatic infrainguinal lower extremity vascular disease and has an intended use for ablating a channel in occlusive peripheral vascular disease. In addition, DABRA has been granted CE mark clearance for the endovascular treatment of infrainguinal arteries via atherectomy and for crossing total occlusions. DABRA excimer lasers and catheters are manufactured in a 32,000-square-foot facility located in Carlsbad, California. The vertically integrated facility is ISO 13485 certified and is licensed by the State of California to manufacture sterile, single-use catheters in clean room environments.

At the Company:
Andrew Jackson
Chief Financial Officer, Ra Medical Systems
760-496-9540
ajackson@ramed.com

Investors:
LHA Investor Relations
Jody Cain
310-691-7100
jcain@lhai.com

Source: Ra Medical Systems, Inc.